Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy

This publication has 34 references indexed in Scilit:

• Results of permanent prostate brachytherapy, 13 years of experience at a single institution
  Radiotherapy and Oncology, 2004
• Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Physikalische Grundlagen und klinische Durchführung der interstitiellen Brachytherapie der Prostata mit Jod-125
  Strahlentherapie und Onkologie, 2002
• Variations in Morbidity after Radical Prostatectomy
  New England Journal of Medicine, 2002
• Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Dose homogeneity as a function of source activity in optimized I-125 prostate implant treatment plans
  International Journal of Radiation Oncology*Biology*Physics, 2001
• 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Retrospective stratification of a consecutive cohort of prostate cancer patients treated with a combined regimen of external-beam radiotherapy and brachytherapy
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Urinary morbidity with a modified peripheral loading technique of transperineal 125i prostate implantation
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706
  International Journal of Radiation Oncology*Biology*Physics, 1991